Mukul Deoras appointed as Colgate-Palmolive India Chairman

FMCG major Colgate-Palmolive India (CPIL) today said its board has appointed Mukul Deoras as Chairman of the company with effect from September 1, 2018.

He replaces Vinod Nambiar whose resignation as Chairman was announced earlier by the company in a regulatory filing on August 1.

The Board of Directors of the company, through a circular resolution passed on August 27, 2018, has appointed Mukul Deoras as a member and the Chairman of the Board of Directors with effect from September 1, 2018, Colgate-Palmolive India said in a filing to BSE.

Most recently, Deoras served as Chief Marketing Officer of Colgate-Palmolive company since August 2015, CPIL said.

Shares of Colgate-Palmolive India (CPIL) today closed at Rs 1,157.80 on BSE, down 0.95 per cent from the previous close.

  • Related Posts

    • Health
    • February 10, 2024
    • 29 views
    Appointment of CEO packs a Punch in NeuroEqulibrium’s Global Goal

    New Delhi: The ambition of NeuroEquilibrium gets a shot in the arm with the appointment of industry vetran Samit Verma as its CEO (Chief Executive Officer). Its global aspiration will…

    Millets reigned Supreme in International Symposium on Gut Health

    New Delhi: Millets reign supreme as gut health assumes most important aspect of the latest preventive and curative healthcare approach. This fact was writ large on Symposium on ‘Gut Health…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs